IBD Cutting Edge 2025 CME Conference: Where Innovation, Trials, and Multidisciplinary Care Intersect

Start: Friday, September 19, 2025 9:00AM
End: Sunday, September 21, 2025 1:00PM

The IBD Cutting Edge 2025 conference will showcase pioneering advancements in translational science, drug discovery, and clinical care for inflammatory bowel disease (IBD). The program will highlight the evolving landscape of clinical trials, innovative therapeutic strategies, and the complexities of managing IBD in diverse patient groups. Key topics will cover disease-specific complications, care considerations for special populations, the role of surgery in IBD management, and the integration of multidisciplinary approaches to enhance treatment outcomes.

Additionally, the conference will introduce emerging technologies, patient-centered care initiatives, and discussions on ensuring equity in access to care. Attendees will benefit from lectures and interactive sessions led by both international and national key opinion leaders in IBD. The comprehensive program will provide healthcare professionals with actionable insights to optimize patient care, advance clinical practices, and improve the quality of life for those living with IBD.

Educational Objectives
After attending this live activity, participants should be able to:
- Explore Translational Science: Describe how emerging insights from translational research are shaping novel therapeutic approaches for inflammatory bowel disease (IBD).
- Analyze Clinical Trial Innovations: Evaluate findings from recent and ongoing clinical trials to inform the development and application of next-generation therapies for IBD.
- Integrate Multidisciplinary Care Strategies: Identify opportunities to optimize patient outcomes through collaborative care models involving gastroenterologists, surgeons, dietitians, psychologists, and other specialists.
- Implement Advanced Surgical and Medical Approaches: Assess the latest advancements in surgical interventions and medical therapies, including their roles in treating complex IBD cases.
- Address Challenges in Special Populations: Examine the unique treatment considerations for pediatric, adolescent, and high-risk IBD populations, ensuring equitable and personalized care.
- Foster Patient-Centered Care: Develop approaches that emphasize shared decision-making and improved quality of life for patients living with IBD.

Prices:
Physicians (MD, DO, MBBS): USD 375.00,
RN, NP, PA, Other: USD 275.00,
Students, Residents, Fellows: USD 175.00

Speakers: Amy Lightner, MD, Scripps Clinic, Gauree Gupta Konijeti, MD, MPH, Scripps Clinic, Mazer Ally, MD, FAGA, FACG, Scripps Clinic, Brigid Boland, MD, UCSD, Rebecca Matro, MD, Scripps Clinic, Siddharth Singh, MD, UCSD